Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Math Biology has developed a non-invasive screening technology that uses biosensors to capture electrical signals from the body. These are analyzed by AI to assess organ health, metabolism, and risk of disease. The company’s Deep Metabolism Assessment platform leverages over 20,000 datasets for early diagnosis and personalized interventions. Recent funding will accelerate product development for both clinical medicine and wellness/sports applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Math Biology.